Summary: A new University of Pittsburgh study overturns a long-standing idea about teenage risk-taking. Rather than being driven by an overactive dopamine system, many adolescents who experiment with alcohol, cannabis, nicotine and other substances appear to do so because they start adolescence with unusually low baseline dopamine. In other words, early experimentation may act as a compensatory boost to an under-stimulated reward system, and it often declines as the brain’s dopamine signaling matures into adulthood.
Using nearly a decade of data from a large national cohort, researchers followed more than 800 young people with repeated behavioral assessments and annual brain scans. By measuring tissue iron in deep brain regions as a validated proxy for long-term dopamine biology, the team identified a distinct “youth peak” trajectory: adolescents who had the lowest baseline reward-system biology were most likely to show an early spike in substance experimentation that then fell sharply by their mid‑twenties as their dopamine measures increased.
Key Facts
- The inverse dopamine finding: Contrary to the common view that high dopamine drives teen risk-taking, this study found that a lower baseline of dopamine-related biology predicts early substance experimentation for a subset of adolescents.
- The youth peak trajectory: Analysis of more than 6,000 repeated assessments revealed multiple developmental pathways. About one group—labeled “youth peak”—showed early, concentrated experimentation followed by a rapid decline in substance use by the mid‑twenties.
- Brain iron as a proxy for dopamine: The researchers used a noninvasive MRI measure of basal ganglia tissue iron, a structural marker that correlates with dopamine-related neurobiology, to track maturation of the reward system over many years.
- Biology precedes use: Because scans were available before and during initial substance exposure, the study could show that low dopamine‑related markers often preceded experimentation rather than resulted from chronic substance use.
- Natural resolution: In the youth peak group, brain measures associated with dopamine rose steadily with age and substance use declined without intervention, suggesting that for many teens experimentation is a temporary, developmentally limited phase.
- Modern alternatives: While the study did not measure social media or screen use, investigators note that rapidly rewarding digital environments have grown as adolescent substance use has fallen, raising the possibility that different reward channels have emerged for low‑dopamine brains.
- Guiding the adaptive drive: Risk-taking is an evolutionarily shaped process that supports the move toward independence. Experts advise channeling this drive into positive, high‑reward pursuits such as team sports, arts, or other social activities rather than attempting to suppress it.
Source: University of Pittsburgh
Headline finding: Teenage experimentation with substances may in many cases reflect a compensatory response to lower baseline dopamine activity in the brain’s reward circuits, according to a study published in Nature Communications by researchers at the University of Pittsburgh School of Medicine.
Lead author Ashley Parr, Ph.D., explains that for some young people taking risks or experimenting with substances may be an involuntary attempt to “get the system going” when dopamine-related reward biology starts off low at the onset of adolescence. This shifts how scientists understand why some teens seek strong rewards and clarifies that higher dopamine is not always the driver of early substance use.
Adolescence is a highly dynamic developmental period marked by exploration, boundary testing and growing independence; these behaviors are part of normal brain maturation. The study shows that not all adolescents follow the same path: while some maintain low or minimal substance use, others follow a temporary early peak in experimentation before tapering off as their neurobiology stabilizes.
The research team measured impulsivity, inhibitory control and self‑reported substance use in more than 800 participants over multiple assessments. They combined these behavioral data with annual MRI measures of basal ganglia tissue iron—an established marker linked to dopamine cell function—to track how reward biology and behavior developed together across adolescence into early adulthood.
Four substance‑use trajectories emerged: no/low use, youth peak (early spike then decline), adolescent increasing, and adult increasing. The youth peak group stood out for having lower tissue iron at baseline and showing a rapid rise in tissue iron and improved self-control over time, coinciding with reduced experimentation.
Parr notes that the critical clinical question is not which teens experiment but which ones continue and escalate into adulthood. Longitudinal markers of early brain and behavior patterns can help distinguish transient, developmentally typical experimentation from trajectories that might require targeted prevention or support.
Although this study did not directly measure screen or social‑media engagement, authors highlight broader cultural trends: youth substance use has declined in many places while digital engagement has increased. The team suggests that fast, highly reinforcing online environments could serve as alternative reward channels for some adolescents and is an important area for future research.
Beatriz Luna, senior author, emphasizes that risk-taking is a normal phase that can be guided rather than eliminated. Families and clinicians can help by directing adolescents toward healthy avenues for novelty and reward—organized sports, creative projects, academic challenges and meaningful social experiences—so the underlying adaptive drive supports positive development.
Authors and collaborators include researchers from the University of Pittsburgh and several other universities. Funding came from multiple sources, including the National Institutes of Health, the National Institute on Alcohol Abuse and Alcoholism, the National Institute on Drug Abuse, and private foundations.
Key Questions Answered:
A: Low baseline dopamine can leave the reward system under‑stimulated. For some adolescents, intense experiences or substance use provide a large, immediate chemical boost that compensates for that deficit. This is an involuntary biological drive rather than a conscious decision to self‑harm.
A: Brain tissue iron in deep reward regions is a structural factor tied to the health and function of dopamine neurons. Longitudinal MRI measures of tissue iron serve as a noninvasive proxy to track dopamine‑related neurobiology over time.
A: No. The study found that for most adolescents who follow a youth peak pattern, experimentation is temporary. As dopamine‑related measures increase during late adolescence and into the mid‑twenties, most reduce or stop substance use without developing long‑term addiction.
Editorial Notes:
- This article was edited for clarity and accuracy.
- The underlying journal paper was reviewed in full.
- Additional context was added by the editorial staff.
About this neuroscience and neurodevelopment research news
Author: Anastasia Gorelova
Source: University of Pittsburgh
Contact: Anastasia Gorelova – University of Pittsburgh
Image credit: Neuroscience News
Original Research: Open access. “Developmental variation in basal ganglia tissue iron, neurocognitive functioning, and impulsivity is associated with substance use trajectories in youth” by Ashley C. Parr et al., published in Nature Communications. DOI: 10.1038/s41467-026-73611-1.
Abstract
Developmental variation in basal ganglia tissue iron, neurocognitive functioning, and impulsivity is associated with substance use trajectories in youth
Neurodevelopmental models implicate dopaminergic and cognitive maturation in adolescent risk‑taking, but how these factors jointly shape substance use trajectories in humans was not well understood. The study examined basal ganglia tissue iron—a marker tied to dopamine biology—alongside measures of impulsivity and inhibitory control in relation to longitudinal substance use patterns in a cohort of 802 participants aged 12–30 with 6,078 visits. Growth mixture models identified four distinct trajectories: no/low use, youth peak, adolescent increasing, and adult increasing. Substance use, inhibitory control and tissue iron all increased with age while impulsivity declined. Greater substance use correlated with higher impulsivity, lower inhibitory control, and lower tissue iron, particularly in early adolescence among youth peak patterns. Divergent maturation of impulsivity and tissue iron further distinguished trajectories. These results indicate that developmental variation in tissue iron and neurocognitive maturation contribute to youth substance use and highlight adolescence as a sensitive period for targeted prevention and risk stratification.